Jane Zochling

6.4k total citations
90 papers, 3.5k citations indexed

About

Jane Zochling is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jane Zochling has authored 90 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Rheumatology, 29 papers in Pathology and Forensic Medicine and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jane Zochling's work include Rheumatoid Arthritis Research and Therapies (34 papers), Spondyloarthritis Studies and Treatments (33 papers) and Systemic Sclerosis and Related Diseases (23 papers). Jane Zochling is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (34 papers), Spondyloarthritis Studies and Treatments (33 papers) and Systemic Sclerosis and Related Diseases (23 papers). Jane Zochling collaborates with scholars based in Australia, Germany and United States. Jane Zochling's co-authors include Jürgen Braun, Susanna Proudman, Wendy Stevens, Janet Roddy, Désirée van der Heijde, Mandana Nikpour, Lyn March, Joanne Sahhar, Peter Nash and J. Brandt and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cochrane Database of Systematic Reviews and Journal of Clinical Epidemiology.

In The Last Decade

Jane Zochling

89 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Zochling Australia 30 2.1k 894 883 655 593 90 3.5k
Markku Korpela Finland 34 2.7k 1.3× 679 0.8× 572 0.6× 693 1.1× 195 0.3× 86 4.0k
Emília Inoue Sato Brazil 33 2.0k 1.0× 1.0k 1.2× 689 0.8× 322 0.5× 453 0.8× 125 3.2k
Umut Kalyoncu Türkiye 26 993 0.5× 606 0.7× 286 0.3× 513 0.8× 409 0.7× 206 2.4k
Helena Forsblad‐d’Elia Sweden 37 2.3k 1.1× 1.0k 1.1× 246 0.3× 587 0.9× 107 0.2× 121 3.5k
Hyoun‐Ah Kim South Korea 31 1.4k 0.7× 1.3k 1.4× 279 0.3× 717 1.1× 134 0.2× 178 3.1k
Matthias Englbrecht Germany 36 2.1k 1.0× 783 0.9× 179 0.2× 657 1.0× 159 0.3× 107 3.2k
Samantha Hider United Kingdom 29 1.3k 0.6× 196 0.2× 470 0.5× 296 0.5× 351 0.6× 135 2.6k
Anne Tournadre France 29 1.2k 0.6× 760 0.9× 249 0.3× 336 0.5× 138 0.2× 145 2.7k
J. M. W. Hazes Netherlands 27 2.1k 1.0× 366 0.4× 265 0.3× 599 0.9× 141 0.2× 61 3.1k
M L Snaith United Kingdom 29 2.5k 1.2× 1.1k 1.3× 715 0.8× 339 0.5× 141 0.2× 79 3.9k

Countries citing papers authored by Jane Zochling

Since Specialization
Citations

This map shows the geographic impact of Jane Zochling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Zochling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Zochling more than expected).

Fields of papers citing papers by Jane Zochling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Zochling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Zochling. The network helps show where Jane Zochling may publish in the future.

Co-authorship network of co-authors of Jane Zochling

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Zochling. A scholar is included among the top collaborators of Jane Zochling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Zochling. Jane Zochling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2017). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.. PubMed. 34 Suppl 100(5). 129–136. 16 indexed citations
2.
Roberts, Lynden, Kathleen Tymms, Geoffrey Littlejohn, et al.. (2017). The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice. International Journal of Rheumatology. 2017. 1–8. 6 indexed citations
3.
Owen, Claire, Gene‐Siew Ngian, O. Moore, et al.. (2017). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.. PubMed. 34 Suppl 100(5). 170–176. 28 indexed citations
4.
Morrisroe, Kathleen, Wendy Stevens, Joanne Sahhar, et al.. (2017). Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Lara D. Veeken. 57(1). 73–83. 22 indexed citations
5.
Hao, Yanjie, Vivek Thakkar, Wendy Stevens, et al.. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research & Therapy. 17(1). 7–7. 88 indexed citations
6.
Littlejohn, Geoffrey, Lynden Roberts, Paul Bird, et al.. (2015). Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study. The Journal of Rheumatology. 42(9). 1603–1609. 12 indexed citations
7.
Hao, Yue, Wendy Stevens, Kathleen Morrisroe, et al.. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal. 44(11). 23–23. 1 indexed citations
8.
Nicholls, Dave, Jane Zochling, David A. Mathers, et al.. (2013). A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in A ustralian rheumatology practice. International Journal of Rheumatic Diseases. 17(7). 755–761. 5 indexed citations
9.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2013). Asymmetric dimethylarginine levels in the early detection of systemic sclerosis-related pulmonary arterial hypertension. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
10.
Nicholls, Dave, Jane Zochling, D A Mathers, et al.. (2012). A retrospective chart review of mabthera (rituximab) for rheumatoid arthritis (Ra) in Australian rheumatology practice. Internal Medicine Journal. 42. 3–3. 1 indexed citations
11.
Stevens, Wendy, Vivek Thakkar, O. Moore, et al.. (2012). LUNG DISEASE IS THE MAJOR CAUSE OF DEATH IN THE AUSTRALIAN SSc COHORT STUDY. Lara D. Veeken. 51. 2 indexed citations
12.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy. 14(3). R143–R143. 91 indexed citations
13.
Byron, J., Jane Zochling, Janet Roddy, et al.. (2011). MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. Internal Medicine Journal. 41. 12–12. 1 indexed citations
14.
Stevens, Wendy, Mandana Nikpour, Julie K. Byron, et al.. (2011). FREQUENCY, CLINICAL CHARACTERISTICS AND RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS. Internal Medicine Journal. 41. 13–13. 3 indexed citations
15.
Zochling, Jane, M. Bohl-Bühler, Xenofon Baraliakos, Ernst Feldtkeller, & Jürgen Braun. (2006). Infection and work stress are potential triggers of ankylosing spondylitis. Clinical Rheumatology. 25(5). 660–666. 15 indexed citations
16.
Seibel, Markus J., Jane Zochling, Lyn March, et al.. (2006). Calcaneal Ultrasound but Not Bone Turnover Predicts Fractures in Vitamin D Deficient Frail Elderly at High Risk of Falls. Calcified Tissue International. 79(1). 37–42. 15 indexed citations
17.
Zochling, Jane & Jürgen Braun. (2005). Management and treatment of ankylosing spondylitis. Current Opinion in Rheumatology. 17(4). 418–425. 14 indexed citations
18.
Zochling, Jane, M. Bohl-Bühler, Xenofon Baraliakos, Ernst Feldtkeller, & Jürgen Braun. (2005). The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms. Clinical Rheumatology. 25(5). 648–658. 11 indexed citations
19.
Zochling, Jane, et al.. (2004). Use of complementary medicines for osteoarthritis—a prospective study. Annals of the Rheumatic Diseases. 63(5). 549–554. 55 indexed citations
20.
Sambrook, Philip N., Lyn March, Ian D. Cameron, et al.. (2004). Serum Parathyroid Hormone Predicts Time to Fall Independent of Vitamin D Status in a Frail Elderly Population. The Journal of Clinical Endocrinology & Metabolism. 89(4). 1572–1576. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026